OPTIC primary analysis: A dose-optimization study of 3 starting doses of ponatinib (PON).
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.7000
Abstract: 7000 Background: PON, a third-generation tyrosine kinase inhibitor (TKI), demonstrated deep and long-lasting responses and survival in patients (pts) with chronic-phase chronic myeloid leukemia (CP-CML) resistant/intolerant to second-generation TKI therapy (PACE; NCT01207440); post hoc analysis… read more here.
Keywords: optic primary; primary analysis; bcr abl1is; analysis ... See more keywords